Table 1. Patient characteristics.
| Cancer type | Cancer site | RTOG | Dose received | Radiosensitivity | Sex | Age | |
|---|---|---|---|---|---|---|---|
| Controls | |||||||
| 1 | Adenocarcinoma | Prostate | 0–1 | 64/32/5 | NA | M | 70 |
| 2 | Adenocarcinoma | Prostate | 0–1 | 64/32/5 | NA | M | 62 |
| 3 | IDC | Breast | 0–1 | 50/25/5 | NA | F | 60 |
| 4 | IDC | Breast | 0–1 | 46/23/5 | NA | F | 70 |
| 5 | Adenocarcinoma | Prostate | 0–1 | 66/33/5 | NA | M | 82 |
| 6 | None | Nil | 0–1 | NA | NA | M | 39 |
| 7 | Adenocarcinoma | Breast | 0–1 | NA | NA | F | 53 |
| 8 | IDC | Breast | 0–1 | 50/25/5 | NA | F | 71 |
| 9 | IDC | Breast | 0–1 | 46/23/5 | NA | F | 47 |
| 10 | Adenocarcinoma | Breast | 0–1 | 46/23/5 | NA | F | 63 |
| 11 | IDC | Breast | 0–1 | 50/25/5 | NA | F | 52 |
| Acute reactors | |||||||
| 1 | IDC | Breast | 3 | 50/25/5 | Erythema, oedema | F | 59 |
| 2 | SCC | Lung | 3 | 36/12/5 | Severe dyspnoea | M | 75 |
| 3 | IDC | Breast | 3 | 18/9/5 | Wet desquamation | F | 44 |
| 4 | SCC | Tonsillar | 3 | 50/25/5 | Mucositis | M | 64 |
| 5 | SCC | Cervical | 3 | 54/30/5 | Sigmoid obstruction | F | 72 |
| 6 | Melanoma | Skin | 3 | 50/25/5 | Desquamation | F | 54 |
| 7 | Seminoma | Testicle | 3 | 16.5/11/4 | Severe nausea, diarrhoea | M | 31 |
| Late reactors | |||||||
| 1 | Adenocarcinoma | Prostate | 3 | 60/30/5 | Rectal bleeding | M | 61 |
| 2 | IDC | Breast | 3 | 46/23/5 | Fibrosis | F | 63 |
| 3 | Adenocarcinoma | Prostate | 3 | 64/32/5 | Rectal bleeding, haematuria | M | 63 |
| 4 | Adenocarcinoma | Prostate | 3 | 64/32/5 | Rectal bleeding | M | 71 |
| 5 | Adenocarcinoma | Prostate | 3 | 66/33/5 | Rectal bleeding | M | 73 |
| 6 | Adenocarcinoma | Prostate | 3 | 64/32/5 | Haematuria | M | 67 |
| 7 | MC | Breast | 3 | 46/23/5 | Fibrosis | F | 51 |
| 8 | SCC | Cervical | 3 | 45/25/5 | Sigmoid and ureter stricture | F | 40 |
| 9 | LC | Breast | 3 | 50/25/5 | Fibrosis, telangiectasia | F | 73 |
| 10 | Adenocarcinoma | Prostate | 3 | 64/32/5 | Rectal bleeding | M | 78 |
| 11 | LC | Lung | 3 | 40/20/5 | Pneumonitis, dyspnoea | F | 69 |
Abbreviations: F=female; IDC=infiltrating ductal carcinoma; LC=lobular carcinoma; M=male; MC=medullary carcinoma; NA=not applicable; RTOG=Radiotherapy Oncology Group; SCC=squamous cell carcinoma.